These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 30827356)
1. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles. Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356 [TBL] [Abstract][Full Text] [Related]
2. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole. Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871 [TBL] [Abstract][Full Text] [Related]
3. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease]. Zhang SS; Wan XY; Zhou CY; Lü WG; Xie X Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443 [TBL] [Abstract][Full Text] [Related]
4. Down-regulation of poly(rC)-binding protein 1 correlates with the malignant transformation of hydatidiform moles. Shi Z; Zhang T; Long W; Wang X; Zhang X; Ling X; Ding H Int J Gynecol Cancer; 2012 Sep; 22(7):1125-9. PubMed ID: 22801034 [TBL] [Abstract][Full Text] [Related]
5. Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients. Hajri T; Massoud M; Vergne M; Descargues P; Allias F; You B; Lotz JP; Haesebaert J; Bolze PA; Golfier F; Massardier J Am J Obstet Gynecol; 2024 Mar; 230(3):362.e1-362.e8. PubMed ID: 37722570 [TBL] [Abstract][Full Text] [Related]
6. Comparative proteomic analysis between benign and malignant-transformed hydatidiform mole. Ma L; Xiang Y; Zhao J; Feng F; Wan X J Reprod Med; 2008 Aug; 53(8):623-8. PubMed ID: 18773628 [TBL] [Abstract][Full Text] [Related]
7. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles. Bolze PA; Patrier S; Cheynet V; Oriol G; Massardier J; Hajri T; Guillotte M; Bossus M; Sanlaville D; Golfier F; Mallet F Placenta; 2016 Mar; 39():116-24. PubMed ID: 26992684 [TBL] [Abstract][Full Text] [Related]
8. Expression of maspin in gestational trophoblastic disease. Li HW; Leung SW; Cheung AN; Yu MM; Chan LK; Wong YF Gynecol Oncol; 2006 Apr; 101(1):76-81. PubMed ID: 16271752 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of patients with lung metastasis of invasive mole before evacuation of hydatidiform mole]. Feng FZ; Xiang Y; Shan Y; Wan XR; Oang XY Zhonghua Fu Chan Ke Za Zhi; 2007 Dec; 42(12):830-3. PubMed ID: 18476517 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN. Teerapakpinyo C; Areeruk W; Tantbirojn P; Phupong V; Shuangshoti S; Lertkhachonsuk R Technol Cancer Res Treat; 2022; 21():15330338211067309. PubMed ID: 35023789 [No Abstract] [Full Text] [Related]
11. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation. Braga A; Maestá I; Matos M; Elias KM; Rizzo J; Viggiano MG Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828 [TBL] [Abstract][Full Text] [Related]
12. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia. Lertkhachonsuk R; Tantbirojn P; Paiwattananupant K J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251 [TBL] [Abstract][Full Text] [Related]
13. Altered p16 and Bcl-2 expression reflects pathologic development in hydatidiform moles and choriocarcinoma. Candelier JJ; Frappart L; Yadaden T; Poaty H; Picard JY; Prévot S; Coullin P Pathol Oncol Res; 2013 Apr; 19(2):217-27. PubMed ID: 23065465 [TBL] [Abstract][Full Text] [Related]
14. Distinct microRNA profiles for complete hydatidiform moles at risk of malignant progression. Lin LH; Maestá I; St Laurent JD; Hasselblatt KT; Horowitz NS; Goldstein DP; Quade BJ; Sun SY; Braga A; Fisher RA; Berkowitz RS; Elias KM Am J Obstet Gynecol; 2021 Apr; 224(4):372.e1-372.e30. PubMed ID: 33031755 [TBL] [Abstract][Full Text] [Related]
15. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation. Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641 [TBL] [Abstract][Full Text] [Related]
16. Decreased expression of epidermal growth factor and its receptor in the malignant transformation of trophoblasts. Ladines-Llave CA; Maruo T; Manalo AM; Mochizuki M Cancer; 1993 Jun; 71(12):4118-23. PubMed ID: 7685239 [TBL] [Abstract][Full Text] [Related]
17. Prediction of Neoplastic Transformation of Hydatidiform Mole: Current Evidence. Laban M; El-Swaify ST; Refaat MA; Ibrahim EA; Abdelrahman RM Reprod Sci; 2021 Oct; 28(10):3010-3012. PubMed ID: 34341951 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios. van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178 [TBL] [Abstract][Full Text] [Related]
19. Differential expression of SALL4 in CTCs derived from hydatidiform moles and gestational trophoblastic neoplasms. Xu D; Feng F; Pei Y; Zhang Y; Wu Y; Guo Y; Cui W Am J Reprod Immunol; 2020 May; 83(5):e13233. PubMed ID: 32187420 [TBL] [Abstract][Full Text] [Related]
20. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Braga A; Maestá I; Rocha Soares R; Elias KM; Custódio Domingues MA; Barbisan LF; Berkowitz RS Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]